Incyte Dermatology Deal History & Licensing Activity
Incyte Dermatology is a biotech headquartered in US. Over the past three years, Incyte Dermatology has been involved in 2 licensing and acquisition transactions, with a primary focus on Other (2 deals). The company currently has 50 active clinical trials, primarily in Hematological Malignancies.
Deals (12mo)
5
Active Trials
50
Top Modality
Other
Focus Area
Hematological Malignancies
Incyte Dermatology Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Incyte Dermatology in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| ICOTYDE | Incyte | Other | Approved | license | Mar 2026 |
| ICOTYDE | Incyte | Small Molecules | Approved | license | Mar 2026 |
Incyte Dermatology Pipeline Focus
Therapeutic areas and modalities where Incyte Dermatology is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Incyte Dermatology Strategic Signals
Key indicators of Incyte Dermatology's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Patent Cliffs
- Undisclosed—
Strategic Profile
Acquisition Appetite
Strategic Priorities
Incyte Dermatology Clinical Pipeline
Incyte Dermatology has 50 active clinical trials across 4 development phases.
1
Unknown
20
Phase 1
24
Phase 2
5
Phase 3
See How Your Asset Matches Incyte Dermatology's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Hematological Malignancies assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Incyte Dermatology Licensing & Deal Activity
Incyte Dermatology is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Incyte Dermatology ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Incyte Dermatology include Hematological Malignancies (10 deals and trials), Solid Tumors (10 deals and trials), Autoimmune (7 deals and trials), and Dermatology (4 deals and trials). In terms of modality, Incyte Dermatology has shown particular interest in other, small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Incyte Dermatology and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Incyte Dermatology's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.